Large-Scale Evidence-Based Guideline Development Engaging the International PCOS Community

Abstract

The evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS) integrates the best available evidence with international, multidisciplinary clinical expertise and consumer preferences to provide health professionals, consumers, and policy makers with high-quality, comprehensive guidance about diagnosing and managing PCOS. Here, we outline the rigorous and systematic process, defined a priori and documented to be reproducible, to minimize bias and maintain transparency, in alignment with the Appraisal of Guidelines for Research and Evaluation (AGREE II) criteria and incorporating the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework that render this PCOS evidence-based guideline credible, trustworthy, reliable, and useable.

Keywords

polycystic ovary syndrome - evidence-based guidelines - AGREE II - GRADE - methodology

• References

• 1 Boyle J, Xu R, Gilbert E, Kuczynska-Burggraf M. , et al. Ask PCOS: identifying need to inform evidence-based app development for polycystic ovary syndrome. Semin Reprod Med 2018; 36 (01) 64-73
• 2 Xie J, Burstein F, Garad R, Teede H, Boyle J. Personalized mobile tool AskPCOS delivering evidence-based quality information about polycystic ovary syndrome. Semin Reprod Med 2018; 36 (01) 74-80
• 3 Garad R, Kozica-Olenski S, Helena J, Teede H. Evaluation of a center of research excellence in polycystic ovary syndrome as a large-scale collaborative research translation initiative, including evaluating translation of guideline impact. Semin Reprod Med 2018; 36 (01) 44-51
• 4 Thomson R, Lavender M, Madhok R. How to ensure that guidelines are effective. BMJ 1995; 311 (6999): 237-242
• 5 Turner T, Misso M, Harris C, Green S. Development of evidence-based clinical practice guidelines (CPGs): comparing approaches. Implement Sci 2008; 3: 45
• 6 Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999; 318 (7182): 527-530
• 7 Misso M, Teede H. Evidence based guideline (EBG) development: a practical guide. In: Ilic D. , ed. Knowledge Transfer: Practices, Types and Challenges. New York, NY: Nova Publishers; 2012
• 8 NHMRC. A Model Framework for Consumer and Community Participation in Health and Medical Research. Canberra, Australia: National Health and Medical Research Council; 2004
• 9 Teede HJ, Misso ML, Deeks AA. , et al; Guideline Development Groups. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust 2011; 195 (06) S65-S112
• 10 Brouwers MC, Kho ME, Browman GP. , et al; AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010; 182 (18) E839-E842
• 11 The AGREE Enterprise. The Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument. Available at: http://www.agreetrust.org/ . Accessed May 2018
• 12 GRADE working group. Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidelines. Available at: http://www.gradeworkinggroup.org/ . Accessed May 2018
• 13 Harris C, Turner T, Wilkinson F. Guideline Development Toolkit. Melbourne, Australia: Centre for Clinical Effectiveness, Southern Health; 2008
• 14 Downes L, Garad R, Teede H, Norman R. A governance model addressing the challenges of contemporary research. Semin Reprod Med 2018; 36 (01) 81-87
• 15 Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2017; 102 (02) 604-612
• 16 Misso ML, Pitt VJ, Jones KM, Barnes HN, Piterman L, Green SE. Quality and consistency of clinical practice guidelines for diagnosis and management of osteoarthritis of the hip and knee: a descriptive overview of published guidelines. Med J Aust 2008; 189 (07) 394-399
• 17 Balen AH, Morley LC, Misso M. , et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update 2016; 22 (06) 687-708
• 18 Brakta S, Lizneva D, Mykhalchenko K. , et al. Perspectives on polycystic ovary syndrome: is polycystic ovary syndrome research underfunded?. J Clin Endocrinol Metab 2017; 102 (12) 4421-4427
• 19 Legro RS, Arslanian SA, Ehrmann DA. , et al; Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013; 98 (12) 4565-4592
• 20 Centre for Clinical Effectiveness. Critical Appraisal Templates. Melbourne, Australia: Centre for Clinical Effectiveness, Southern Health; 2010
• 21 Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]: The Cochrane Collaboration; 2011
• 22 Moher D, Liberati A, Tetzlaff J, Altman DG. ; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6 (07) e1000097
• 23 Vermeulen N, Le Clef N, D'Angelo A, Tilleman K, Veleva Z, Nelen W. Manual for ESHRE Guideline Development. Version 3.0. European Society of Human Reproduction and Embryology; 2017